Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ). Geänderte Risikoinformationen zu der Hormonspirale Mirena. Newsletter 2007-108 of June 19, 2007.
Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen‐releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2020; (6): CD002126.
Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol 2011; 18(3): 303-309.
Correa TD, Caetano IM, Saraiva PH et al. Use of GnRH Analogues in the Reduction of Submucous Fibroid for Surgical Hysteroscopy: A Systematic Review and Meta-Analysis. Rev Bras Ginecol Obstet 2020; 42(10): 649-658.
Hartmann KE, Fonnesbeck C, Surawicz T et al. Management of Uterine Fibroids. (AHRQ Comparative Effectiveness Reviews; Band 195). 2017.
Jiang W, Shen Q, Chen M, Wang Y, Zhou Q, Zhu X et al. Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review. Steroids 2014; 86: 69-78.
Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid 2015.
Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; (2): CD000547.
Moroni RM, Martins WP, Dias SV, Vieira CS, Ferriani RA, Nastri CO et al. Combined oral contraceptive for treatment of women with uterine fibroids and abnormal uterine bleeding: a systematic review. Gynecol Obstet Invest 2015; 79(3): 145-152.
Murji A, Whitaker L, Chow TL, Sobel ML. Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database Syst Rev 2017; (4): CD010770.
Sangkomkamhang US, Lumbiganon P, Laopaiboon M, Mol BW. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev 2013; (2): CD008994.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.